News & Updates

Even after the dabigatran-specific reversal agent idarucizumab has been made available, dabigatran continues to be safe and well-tolerated for stroke and systemic embolism prevention in patients with nonvalvular atrial fibrillation (NVAF), reports a recent Japan study.

Paracetamol is as safe and effective as ibuprofen or indomethacin in the treatment of patent ductus arteriosus (PDA) in preterm neonates, suggests a recent study. In addition, use of paracetamol results in fewer adverse effects.

Race or ethnicity does not appear to contribute to abnormal semen parameters in men undergoing semen analysis (SA) after controlling for body mass index (BMI), insurance status, and neighbourhood income, according to a study.

The C5 and leukotriene B4 inhibitor nomacopan helps suppress acute flares in older patients with bullous pemphigoid, according to the results of a phase IIa study.

Older patients, as well as those with malignancies or cardiovascular diseases, may experience substantial diagnostic delay for Guillain-Barré syndrome (GBS), a recent study has found.

One-week vonoprazan-based triple therapy is well tolerated and has comparable efficacy as the 2-week proton pump inhibitor (PPI)-based triple therapy for first-line Helicobacter pylori eradication, according to a study.